Ataxia-telangiectasia

14,162views

Ataxia-telangiectasia

BIIC

BIIC

Anemia of chronic disease
Lead poisoning
Vitamin B12 deficiency
Macrocytic anemia: Pathology review
Megaloblastic anemia
Microcytic anemia: Pathology review
Beta-thalassemia
Alpha-thalassemia
Hereditary spherocytosis
Sickle cell disease (NORD)
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Pyruvate kinase deficiency
Platelet plug formation (primary hemostasis)
Coagulation (secondary hemostasis)
Role of Vitamin K in coagulation
Clot retraction and fibrinolysis
Anticoagulants: Heparin
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Hemophilia
Antithrombin III deficiency
Protein C deficiency
Vitamin K deficiency
Von Willebrand disease
Bernard-Soulier syndrome
Glanzmann's thrombasthenia
Hemolytic-uremic syndrome
Immune thrombocytopenia
Thrombotic thrombocytopenic purpura
Factor V Leiden
Protein S deficiency
Antiphospholipid syndrome
Disseminated intravascular coagulation
Heparin-induced thrombocytopenia
Antiplatelet medications
Thrombolytics
Hematopoietic medications
Polycythemia vera (NORD)
Essential thrombocythemia (NORD)
Blood groups and transfusions
Thymus histology
Spleen histology
Lymph node histology
Contracting the immune response and peripheral tolerance
Sepsis
Autoimmune hemolytic anemia
Staphylococcus epidermidis
Enterococcus
Streptococcus pneumoniae
Escherichia coli
Klebsiella pneumoniae
Enterobacter
Protein synthesis inhibitors: Aminoglycosides
Mechanisms of antibiotic resistance
Cell wall synthesis inhibitors: Cephalosporins
Cell wall synthesis inhibitors: Penicillins
Miscellaneous cell wall synthesis inhibitors
DNA synthesis inhibitors: Fluoroquinolones
Miscellaneous protein synthesis inhibitors
Protein synthesis inhibitors: Tetracyclines
Blood products and transfusion: Clinical
Salmonella typhi (typhoid fever)
Borrelia burgdorferi (Lyme disease)
Leptospira
Borrelia species (Relapsing fever)
Rickettsia rickettsii (Rocky Mountain spotted fever) and other Rickettsia species
Ehrlichia and Anaplasma
Yellow fever virus
Dengue virus
Zika virus
West Nile virus
Plasmodium species (Malaria)
Antimalarials
Babesia
Hodgkin lymphoma
Non-Hodgkin lymphoma
Chronic leukemia
Acute leukemia
Myelofibrosis (NORD)
Myelodysplastic syndromes
Lymphomas: Pathology review
Leukemias: Pathology review
Wiskott-Aldrich syndrome
Ataxia-telangiectasia
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Giardia lamblia
Entamoeba histolytica (Amebiasis)
Toxoplasma gondii (Toxoplasmosis)
Trypanosoma cruzi (Chagas disease)
Leishmania
Trypanosoma brucei
Strongyloides stercoralis
Wuchereria bancrofti (Lymphatic filariasis)
DNA synthesis inhibitors: Metronidazole
Antimetabolites: Sulfonamides and trimethoprim
Plasma cell disorders: Pathology review
HIV (AIDS)

Transcript

Watch video only

With ataxia telangiectasia, ataxia refers to poor coordination and telangiectasia refers to dilated blood vessels, which are the two key symptoms of this disease.

Ataxia telangiectasia develops when a genetic mutation causes the lack of a protein called ataxia telangiectasia mutated serine-threonine kinase, or just ATM for short, which normally fixes up damaged DNA.

DNA of every cell gets damaged over and over again from various environmental factors like radiation and chemical toxins.

Now, one of the most severe types DNA damage is a double-strand break, where both strands of the DNA’s double helix are severed, damaging the genetic information that was stored there. To help with this sort of repair, there’s a protein called ATM.

ATM is primarily located in the cell's nucleus, and you can sort of think of ATM as like a manager of the DNA’s repair.

It’s protein kinase, which means that it uses it’s managing skills to activate other proteins through phosphorylation, which is the addition of a phosphoryl or -PO32− group.

So at the site of the double strand break, ATM phosphorylates proteins like the tumor suppressor protein p53, that stop the cell from reproducing.

ATM also phosphorylates additional proteins which will either fix the DNA or kill the faulty cell through a process of apoptosis - controlled cell death. This way we don't end up with a bunch of defective cells trying to reproduce.

That's the main role of ATM, but it also plays a role in the development of immune cells, especially T lymphocytes.

T lymphocytes need to be able to recognize a wide variety of antigens, and to do this, they purposefully create double strand breaks in their DNA during development. That way parts of their DNA can get rearranged, and code for new and unique antigen receptors.

Once again, ATM helps to fix these breaks - and that keeps the T-cells functioning normally.

In ataxia telangiectasia, there's an autosomal recessive mutation of the ATM gene.

This leads to a decrease in the amount of functioning ATM protein, and as a result, cells that undergo a double-strand break don't have sufficient ATM to repair the break.

As a result, some of the damaged cells might survive and continue to proliferate despite the damage, but most ultimately die off.

Now, if cells start dying off left-right-and-center that’s a big problem.

This can especially impact the nervous system.

When the cerebellum’s affected, it atrophies, and since the cerebellum coordinates movement, this degeneration is what causes the ataxia, or or difficulty with coordination and movement, in lots of individuals with the disease.

In many cases, the ataxia can lead to the muscles in the mouth and throat not coordinating, which can cause aspiration pneumonia. That’s where bits of food, liquid, and body secretions are able to enter the airways, and cause direct damage as well as infection in the lungs.

Key Takeaways

Ataxia-telangiectasia (A-T) also called Louis-Bar Syndrome, is an autosomal recessive condition characterized by progressive cerebellar atrophy and oculocutaneous telangiectasia (small dilated vessels under the skin). People with A-T often have high rates of cancer and immunodeficiency disorders. It is caused by a mutation of the ataxia telangiectasia mutated (ATM) gene, and it is characterized by poor muscle coordination or ataxia (often needing a wheelchair by the age of 10), dysarthria, and telangiectasia on the skin and eyes.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  5. "A Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase" Science (1995)
  6. "Consequences of the Delayed Diagnosis of Ataxia-Telangiectasia" Pediatrics (1998)
  7. "Ataxia telangiectasia" Seminars in Pediatric Neurology (1998)
  8. "DNA damage-induced activation of ATM and ATM-dependent signaling pathways" DNA Repair (2004)
  9. "Early diagnosis of ataxia-telangiectasia using radiosensitivity testing" The Journal of Pediatrics (2002)